Netherlocks partial stroke system meets SIL 3
According to FMEDA report by Exida, the Netherlocks partial stoke system FAITH (Fail Action Integrity Test Handling) is very reliable
The FAITH system makes it possible to carry out a manually initiated partial stroke test on ESD (Emergency Shut Down) valves during normal operation, without interrupting process flow. It limits, with mechanical stops, the angle of the stroke of the valve-actuator combination to a set percentage – ensuring the ESD valve ‘works’, without actually shutting down the operation. By operating mechanically rather than relying on electronic contacts or signals, reliability and simplicity is maximised.
An FMEDA (Failure Modes, Effects, and Diagnostic Analysis) assessment has been carried out by Exida on Netherlocks’ FAITH system. The product was subject to a thorough examination according to IEC 61508 to determine Probability of Failure on Demand (PFD) statistics for this device. The failure rates of the FAITH System must be added to the failure rates of the valve-actuator combination when determining the PFD AVG and Safe Failure Fraction (SFF) for the final element.
More details, a summary and the report itself are available to customers upon request from sales@netherlocks.com or at www.netherlocks.com.
You may also like
Trending Articles
You may also like
Manufacturing
SCHOTT Pharma launches EVERIC lyo & amber vials for light-sensitive ADCs
Featuring the well-known EVERIC® lyo coating, EVERIC® lyo & amber is designed for lyophilised, light-sensitive antibody-drug-conjugates (ADCs). It offers reliable light protection at the primary packaging level, already during the fill-and-finish process. EVERIC amber is the first specialty vial for highly light-sensitive medications that simultaneously meets regulatory light transmission requirements in the EU, the U.S., and Japan
You need to be a subscriber to read this article.
Click here to find out more.
Click here to find out more.
Manufacturing
Portable gas detection in the pharmaceutical sector
Gas safety is a critical consideration in the pharmaceutical sector. Hazardous gases and airborne contaminants are common by-products of manufacturing processes … and employers must control worker exposure in accordance with relevant legislation and industry standards
Manufacturing
New legal duties for QPs in decentralised manufacturing
In this clip, Dr. Peter Gough explains that QPs will be responsible for supervising decentralised activities, conducting regular audits, carrying out periodic on-site visits, confirming GMP compliance to regulatory authorities and notifying changes that may affect quality or safety
Manufacturing
FDA escalates action against Dabur India over systemic data-integrity and cGMP failures
The US FDA has issued a warning letter to Dabur India following an inspection that identified falsified records, missing laboratory data, inadequate cleaning and process validation and weaknesses in quality-unit oversight, saying the company's response failed to address the systemic nature of the deficiencies
Manufacturing
DNA Script and GE Healthcare awarded $26m ARPA-H funding to scale cell-free DNA bioproduction
The pair will combine DNA Script's EDS technology with GE HealthCare's DNA scaling technology to create a faster, more flexible manufacturing process for cell-free DNA as the use of personalised and time-sensitive genetic medicines grows